As of 3:59pm ET
| -0.11 / -4.76%|
The 6 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 7.25, with a high estimate of 9.50 and a low estimate of 3.50. The median estimate represents a +229.55% increase from the last price of 2.20.
The current consensus among 6 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.